Table 2.

Results of TSEB.

	36 Gy	12 Gy
Overall response	100% (6/6)	87.5% (7/8)
Complete response	67% (4/6) 2 patients stage IIB 1 patient stage IIIA 1 patient SS	25% (2/8) 2 patients stage IB
Partial response	33% (2/6) 1 patient stage IIIA 1 patient SS	62.5% (5/8) 1 patient stage IIA 2 patients stage IIB 1 patient stage IIIA 1 patient SS
No response	–	12.5% (1/8) 1 patient stage IIIA
Median duration of response	10.5 months	9.25 months
Median duration of clinical benefit	11.5 months	10.1 months